Characterization of a DNA topoisomerase encoded by Amsacta moorei entomopoxvirus

Virology

Volumn 230, Issue 2, 1997, Pages 197-206

  Petersen, Birgitte ø ^a   Hall, Richard L ^b   Moyer, Richard W ^b   Shuman, Stewart ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENTOMOPOXVIRUS; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME PURIFICATION; PRIORITY JOURNAL; VACCINIA VIRUS;

AMSACTA; AMSACTA MOOREI; AMSACTA MOOREI ENTOMOPOXVIRUS; ORF VIRUS; RABBIT FIBROMA VIRUS; UNIDENTIFIED ENTOMOPOXVIRUS; VACCINIA; VACCINIA VIRUS; VERTEBRATA;

EID: 0030993708     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8495     Document Type: Article

References (39)

1. Arif B. M. Recent advances in the molecular biology of entomopoxviruses. J. Gen. Virol. 76:1995;1-13.
2. Caron P. R., Wang J. C. Alignment of primary sequences of DNA topoisomerases. Adv. Pharmacol. 29B:1994;271-297.
3. Champoux J. J. Mechanistic aspects of type I topoisomerases. DNA topology and Its Biological Effects. 1990;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 217-242.
4. Davison A. J., Moss B. Structure of vaccinia virus late promoters. J. Mol. Biol. 210:1989;771-784.
5. Eng W., Pandit S. D., Sternglanz R. Mapping the active site tyrosine of eukaryotic DNA topoisomerase I. J. Biol. Chem. 264:1989;13373-13376.
6. Gruidl M. E., Hall R. L., Moyer R. W. Mapping and molecular characterization of a functional thymidine kinase ofAmsacta moorei. Virology. 186:1992;507-516.
7. Hanai R., Wang J. C. Protein footprinting by the combined use of reversible and irreversible lysine modifications. Proc. Natl. Acad. Sci. USA. 91:1994;11904-11908.
8. Hall R. L., Moyer R. W. Identification, cloning, and sequencing of a fragment ofAmsacta moorei. J. Virol. 65:1991;6516-6527.
9. Klemperer N., Traktman P. Biochemical analysis of mutant alleles of the vaccinia virus topoisomerase I carrying targeted substitutions in a highly conserved domain. J. Biol. Chem. 268:1993;15887-15899.
10. Klemperer N., Lyttle D. J., Tauzin D., Traktman P., Robinson A. J. Identification and characterization of the orf virus type I topoisomerase. Virology. 206:1995;203-215.
11. Lynn R. M., Bjornsti M-A., Caron P. R., Wang J. C. Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine ofSaccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 86:1989;3559-3563.
12. Morham S. G., Shuman S. Phenotypic selection and characterization of mutant alleles of a eukaryotic DNA topoisomerase I. Genes Dev. 4:1990;515-524.
13. Morham S. G., Shuman S. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I. J. Biol. Chem. 267:1992;15984-15992.
14. Moyer R. W. Entomopoxviruses. Webster R. G., Granoff A. Encyclopedia of Virology. 1994;392-397 Academic Press, London.
15. Palaniyar N., Fisher C., Parks R., Evans D. H. SFV topoisomerase: Sequence specificity in a genetically marked interval. Virology. 221:1996;351-354.
16. Petersen B. Ø., Wittschieben J., Shuman S. Mutations within a conserved region of vaccinia topoisomerase affect the cleavage-religation equilibrium. J. Mol. Biol. 263:1996;181-195.
17. Petersen B. Ø., Shuman S. Histidine-265 is important for covalent catalysis by vaccinia topoisomerase and is conserved in all eukaryotic type I enzymes. J. Biol. Chem. 1997.
18. Poddar S. K., Bauer W. R. Type I topoisomerase activity after infection of enucleated synchronized mouse L cells by vaccinia virus. J. Virol. 57:1986;433-437.
19. Sekiguchi J., Shuman S. Vaccinia topoisomerase binds circumferentially to DNA. J. Biol. Chem. 269:1994a;31731-31734.
20. Sekiguchi J., Shuman S. Stimulation of vaccinia topoisomerase I by nucleoside triphosphates. J. Biol. Chem. 269:1994b;29760-29764.
21. Sekiguchi J., Shuman S. Proteolytic footprinting of vaccinia topoisomerase bound to DNA. J. Biol. Chem. 270:1995;11636-11645.
22. Sekiguchi J., Shuman S. Identification of contacts between topoisomerase I and its target DNA by site-specific crosslinking. EMBO J. 15:1996;3448-3457.
23. Senkevich T. G., Bugert J. J., Sisler J. R., Koonin E. V., Darai G., Moss B. Genomic sequence of a human tumorigenic poxvirus: Prediction of specific host response-evasion genes. Science. 273:1996;813-816.
24. Shaffer R., Traktman P. Vaccinia virus encapsidates a novel topoisomerase with the properties of a eukaryotic type I enzyme. J. Biol. Chem. 262:1987;9309-9315.
25. Shuman S. Site-specific DNA cleavage by vaccinia virus DNA topoisomerase I. J. Biol. Chem. 266:1991a;1796-1803.
26. Shuman S. Site-specific interaction of vaccinia virus topoisomerase I with duplex DNA. J. Biol. Chem. 266:1991b;11372-11279.
27. Shuman S. DNA strand transfer reactions catalyzed by vaccinia topoisomerase I. J. Biol. Chem. 267:1992a;8620-8627.
28. Shuman S. Two classes of DNA end-joining reactions catalyzed by vaccinia topoisomerase I. J. Biol. Chem. 267:1992b;16755-16758.
29. Shuman S., Moss B. Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc. Natl. Acad. Sci. USA. 84:1987;7478-7482.
30. Shuman S., Prescott J. Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I. J. Biol. Chem. 265:1990;17826-17836.
31. Shuman S., Turner J. Site-specific interaction of vaccinia virus topoisomerase I with base and sugar moieties in duplex DNA. J. Biol. Chem. 268:1993;18943-18950.
32. Shuman S., Golder M., Moss B. Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli. J. Biol. Chem. 263:1988;16401-16407.
33. Shuman S., Golder M., Moss B. Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: Evidence that the gene is essential for virus growth. Virology. 170:1989a;302-306.
34. Shuman S., Kane E. M., Morham S. G. Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I. Proc. Natl. Acad. Sci. USA. 86:1989b;9793-9797.
35. Stivers J. T., Shuman S., Mildvan A. S. Vaccinia DNA topoisomerase I: Single-turnover and steady-state kinetic analysis of the strand cleavage and ligation reactions. Biochemistry. 33:1994;327-339.
36. Upton C., Opgenorth A., Traktman P., McFadden G. Identification and DNA sequence of the Shope fibroma virus DNA topoisomerase gene. Virology. 176:1990;439-447.
37. Wittschieben J., Shuman S. Mutational analysis of vaccinia [cl10]DNA topoisomerase defines amino acid residues essential for covalent catalysis. J. Biol. Chem. 269:1994;29978-29983.
38. Yuen L., Moss B. Oligonucleotide sequence signaling transcription termination of vaccinia virus early genes. Proc. Natl. Acad. Sci. USA. 84:1987;6417-6421.
39. Zantige J. L., Krell P. J., Derbyshire J. B., Nagy E. Partial transcriptional mapping of the fowlpox genome and analysis of theEco. J. Gen. Virol. 77:1996;603-614.